• Signed Joint Development and Sales Agreement with Black Diamond Structures for combined Anteo X™ product
• Achieved significant technical milestone for Ultranode™ X anode configuration
• Appointed South Korean distributor Kangshin Industrial Co., Ltd to access rapidly expanding battery market
• Life Sciences business secures new sales opportunities and strengthens long-term client relationships

AnteoTech Ltd, a global supplier of chemicals and advanced material solutions, provided an update on its activities and quarterly cashflow for the period ended 30 September 2025. The company continued to execute its revised strategy, expanding its sales pipeline across the Advanced Battery Technologies (ABT) and Life Sciences (LS) business units. Key highlights include: ABT - Signed a Joint Development and Sales Agreement with US-based Black Diamond Structures to commercialize a combined Anteo X™/Molecular Rebar™ product; achieved a significant technical milestone for the Ultranode™ X anode configuration; appointed South Korean distributor Kangshin Industrial Co., Ltd to access the rapidly expanding battery market; and engaged with manufacturers on a new battery separator additive product. LS - Expanded market engagement and lead generation through attendance at key conferences; received a sizable order from a long-term customer; and initiated negotiations for a co-development of a chemiluminescence immunoassay diagnostic product. The company also made progress on corporate initiatives, including building commercial capabilities, delivering cost reductions, and commencing a strategic review of expansion opportunities.

AnteoTech expects to commence sales of the combined Anteo X™/Molecular Rebar™ product with Black Diamond Structures in the second half of FY2026.

The company is focused on driving sales growth, identifying collaborative and strategic partnerships, and building long-term shareholder value across its Advanced Battery Technologies and Life Sciences business units.